DrugPatentWatch Database Preview
ORTHO-NOVUM 7/7/7-21 Drug Profile
When do Ortho-novum 7/7/7-21 patents expire, and when can generic versions of Ortho-novum 7/7/7-21 launch?
Ortho-novum 7/7/7-21 is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in ORTHO-NOVUM 7/7/7-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Recent Litigation for ORTHO-NOVUM 7/7/7-21
Identify potential future generic entrants
District Court Litigation
Case Name | Date |
---|---|
Teva Women's Health, Inc. v. Famy Care Ltd. | 2014-12-05 |
JANSSEN PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. | 2008-10-16 |
ORTHO-MCNEIL PHARM v. BARR LABORATORIES |
Synonyms for ORTHO-NOVUM 7/7/7-21
(17 alpha)-17-hydroxy-19-norpregn-4-en-20-yn-3-one, mixture with (17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol |
(17alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one, mixture with (17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol |
19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, mixed with 19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol |
37270-71-6 |
53464-69-0 |
AC1L1Y1Y |
Alyacen 1/35 |
Alyacen 7/7/7 |
Aranelle |
Balziva |
Balziva-21 |
Balziva-28 |
Binovum |
BREVICON 21-DAY |
BREVICON 28-DAY |
Brevion |
C20H24O2.C20H26O2 |
Con-fer |
Cyclafem 1/35 |
Cyclafem 7/7/7 |
Cyonanz |
DT 5061 |
DT 5062 |
DT-5061 |
DT-5062(1/35) |
Duagynon |
E-Con |
Ethinyl estradiol mixture with norethindrone |
ETHINYL ESTRADIOL; NORETHINDRONE |
Ethinylestradiol-norethisterone mixt |
Ethinylestradiol-norethisterone mixt. |
Ethynyl estradiol / norethindrone |
Ethynylestradiol / norethindrone |
Ethynylestradiol mixed with norethindrone |
ethynylestradiol mixture with norethindrone |
Eve 20 |
Femcon Fe |
GENCEPT 10/11-21 |
GENCEPT 10/11-28 |
Gynovlar |
Kaitlib Fe |
Leena |
Lo Minastrin Fe |
LoDose |
LS-178555 |
LS-97443 |
MODICON 21 |
MODICON 28 |
N.E.E. 1/35 21 |
N.E.E. 1/35 28 |
N049500000 |
Necon 7/7/7 28-Day Tablets |
Neocon |
Netasyn |
NORCEPT-E 1/35 21 |
NORCEPT-E 1/35 28 |
NORETHIN 1/35E-21 |
NORETHIN 1/35E-28 |
Norethindron-ethinylestradiol mixt |
Norethindron-ethinylestradiol mixt. |
Norethindrone / Ethinyl estradiol |
norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination |
NORETHINDRONE AND ETHINYL ESTRADIOL |
NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) |
NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) |
Norethindrone Ethinyl Estradiol |
Norethindrone mixed with ethynylestradiol |
Norethindrone mixture with ethinyl estradiol |
Norethindrone-ethinylestradiol mixt |
Norethindrone-ethinylestradiol mixt. |
Norethisterone mixed with ethinyl oestradiol |
Norethisterone-ethinylestradiol mixt |
Norethisterone-ethinylestradiol mixt. |
Norethisterone-ethynylestradiol mixt |
Norethisterone-ethynylestradiol mixt. |
Norimen |
Norimin |
Norinyl 1 35 |
Norinyl 1-35 |
NORINYL 1+35 21-DAY |
NORINYL 1+35 28-DAY |
Norminest |
Nortrel 0.5/35-21 |
Nortrel 0.5/35-28 |
Nortrel 1/35-21 |
Nortrel 1/35-28 |
Nortrel 7/7/7 |
Nylia 1/35 |
Nylia 7/7/7 |
Oestro-primolut |
Ortho Novum 7-7-7 |
Ortho-Novum 1/35 |
ORTHO-NOVUM 1/35-21 |
ORTHO-NOVUM 1/35-28 |
Ortho-novum 10/11 |
ORTHO-NOVUM 10/11-21 |
Ortho-Novum 10/11-28 |
ORTHO-NOVUM 7/14-21 |
ORTHO-NOVUM 7/14-28 |
Ortho-novum 7/7/7 |
ORTHO-NOVUM 7/7/7-28 |
Ortho-Novum 777 |
Ovcon 35 |
Ovcon 50 |
OVCON-35 |
OVCON-50 |
Ovyrmen |
Ovysmen |
Primidos |
SCHEMBL3835489 |
SH 7.1122 |
SH B 259 AB |
TRI-NORINYL 21-DAY |
TRI-NORINYL 28-DAY |
Trinovum |
Zenchent |
Zoran |
Paragraph IV (Patent) Challenges for ORTHO-NOVUM 7/7/7-21
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
ORTHO-NOVUM 7/7/7-21 | TABLET;ORAL-21 | ethinyl estradiol; norethindrone | 018985 | |
ORTHO-NOVUM 7/7/7-28 | TABLET;ORAL-28 | ethinyl estradiol; norethindrone | 018985 |
US Patents and Regulatory Information for ORTHO-NOVUM 7/7/7-21
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORTHO-NOVUM 7/7/7-21
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | Start Trial | Start Trial |
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | Start Trial | Start Trial |
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | Start Trial | Start Trial |
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |